USNA (Usana Health Sciences) Total Liabilities : $161.9 Mil (As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Usana Health Sciences Total Liabilities?

Usana Health Sciences's Total Liabilities for the quarter that ended in Dec. 2024 was $161.9 Mil.

Usana Health Sciences's quarterly Total Liabilities increased from Jun. 2024 ($119.21 Mil) to Sep. 2024 ($138.22 Mil) and increased from Sep. 2024 ($138.22 Mil) to Dec. 2024 ($161.86 Mil).

Usana Health Sciences's annual Total Liabilities declined from Dec. 2022 ($162.08 Mil) to Dec. 2023 ($135.56 Mil) but then increased from Dec. 2023 ($135.56 Mil) to Dec. 2024 ($161.86 Mil).

Usana Health Sciences Total Liabilities Historical Data

The historical data trend for Usana Health Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Total Liabilities Chart

Usana Health Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

199.24

182.62

162.08

135.56

161.86

Usana Health Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															129.29	119.21	138.22	161.86	162.72

Usana Health Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Usana Health Sciences's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.625	+	(0	+	18.163
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.073	+	0	+	0)
	=	161.9

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	748.193	-	586.332
	=	161.9

Usana Health Sciences's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.625	+	(0	+	18.163
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.073	+	0	+	0)
	=	161.9

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	748.193	-	586.332
	=	161.9

Usana Health Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Usana Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (NYSE:USNA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

USJ:Germany

Address

3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120

Website

https://www.usana.com

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Executives

Brent Neidig	officer: CO & Man. Dir. of China	3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120
Joshua Foukas	officer: Chief Legal Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120
John Turman Fleming	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
David Mulham Mulham	officer: Chief Field Development Office	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Gilbert A Fuller	officer: CFO and Executive V.P.	55 WANDERWOOD WAY, SANDY UT 84092
Jim Brown	officer: Chief Production Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Peggie Pelosi	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84111
Paul A. Jones	officer: CFO	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Myron W Wentz	director	3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
G Doug Iiekking	officer: VP of Finance	C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
Daniel A. Macuga	officer: Chief Communications Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Kevin Guest	officer: E.V.P. of Marketing	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Walter Noot	officer: Chief Information Officer	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Robert A Sinnott	officer: Chief Scientific Officer	400 55 WATER STREET, VANCOUVER A1 V6B1A1
Frederic J Winssinger	director	2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018